Intuit Inc. vs McKesson Corporation — how do they compare? Intuit Inc. trades at $332.99 (market cap $92.03B), while McKesson Corporation trades at $899.7 (market cap $105.14B). The key difference: Intuit Inc. and McKesson Corporation are close in size by market cap, and Intuit Inc. pays the higher dividend (1.43%). Which is the better fit depends on your goals.
| INTU | MCK | |
|---|---|---|
Market Cap | $92.03B | $105.14B |
Sector | Technology | Health |
52-Week High | $717.21 | $995.69 |
52-Week Low | $255.07 | $659.01 |
Enterprise Value | $90.49B | $111.67B |
Dividend Yield | 1.43% | 0.42% |
Signals from Pluang's Aura AI — not financial advice
Intuit (INTU) trades at $336.44, up 3.44% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $18.83B in 2025, with a net income margin of 20.54%, while analyst consensus is a Buy with a $401 price target. However, recent news highlights a 20% stock drop and securities fraud investigations related to TurboTax pricing issues, creating near-term uncertainty.
The outlook is mixed: strong fundamentals and AI-driven growth in financial software support upside, but legal risks and investor sentiment pressure pose challenges. Valuation metrics like a P/E of 20.4 appear reasonable if execution continues, yet volatility may persist until legal concerns resolve.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte). Founded in the mid-1980s, Intuit controls the majority of U.S. market share for small-business accounting and DIY tax-filing software.
Read more on INTU →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →